SCHEMBL30677147

SCHEMBL30677147

Cc1cc(C(C)(C)O)nn1-c1ccc(Br)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.41
▸ MAPT P10636 4/20 0.38
▸ RECQL P46063 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMPD1 P17405 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PTGS1 P23219 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAPK14 Q16539 1/20 0.35
▸ RIPK1 Q13546 1/20 0.35
▸ AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19435170 0.83 NPY5R (0.44) ALDH1A1POLBNPSR1MAPK14RIPK1
SCHEMBL25184267 0.82 PTGS2 (0.54) PTGS2MAPTALDH1A1KDM4EPTGS1
SCHEMBL30677159 0.80 MAPK14 (0.44) MAPTALDH1A1POLBCDK8NPSR1
SCHEMBL31546285 0.80 SLC34A1 (0.44) MAPTALDH1A1NPSR1TDP1RIPK1
SCHEMBL31546295 0.78 CRACR2A (0.43) —
SCHEMBL4231163 0.75 MAPT (0.59) PTGS2MAPTRECQLGAAALDH1A1
SCHEMBL9910542 0.74 CDK8 (0.55) MAPTNPC1RAB9ACDK8MAPK14
SCHEMBL21821553 0.71 SMPD1 (0.49) PTGS2SMPD1ALDH1A1
SCHEMBL14314274 0.70 PRKCZ (0.55) PTGS2POLBCDK8PTGS1MAPK14
SCHEMBL12847029 0.70 CDK8 (0.44) PTGS2MAPTRECQLNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543890-A1 USP1 INHIBITORS AND USES THEREOF Forma Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
CN-119731178-A USP1 inhibitors and uses thereof 福马治疗有限公司 2025-03-28 — — CN disclosed
WO-2023250084-A1 USP1 INHIBITORS AND USES THEREOF FORMA THERAPEUTICS, INC. (US) 2023-12-28 — — WO disclosed
Send feedback